Drug-Induced Interstitial Lung Diseases Associated with Molecular-Targeted Anticancer Agents-Reference-Cited by-同舟云学术

Drug-Induced Interstitial Lung Diseases Associated with Molecular-Targeted Anticancer Agents

Published:2009 Issue:1 Volume:76 Page:4-8
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Gemma Akihiko¹

Affiliation:

1. Division of Pulmonary Medicine, Infection Diseases and Oncology, Graduate School of Medicine, Nippon Medical School

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Link

http://www.jstage.jst.go.jp/article/jnms/76/1/76_1_4/_pdf

Reference10 articles.

1. 1. Final report of the expert committee on acute lung diseases/interstitial pneumonia due to gefitinib (Irresa^® Tablets 250), AstraZeneca, March 2003.

2. 2. "Results and discussion of the prospective survey on the use of Irresa^® Tablets 250 (Special survey)", AstraZeneca, August 2004.

3. 3. Kudoh S, Kato H, Nishiwaki Y, et al.: Japan Thoracic Radiology Group Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med 2008; 177: 1348-1357.

4. 4. Gemma A: Special article "The science of adverse reaction": II Outline of adverse reaction; 14) anticancer agents; d) interstitial pneumonia [in Japanese]. Jap J Clin Med (Nihon Rinsyo) 2007; 65 (Supple 8): 299-303.

5. 5. Gemma A: Lung diseases due to anti-malignant tumor agents [in Japanese]. Clin Oncology (Shuyo Naika) 2007; 1: 177-183.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review;Expert Review of Anticancer Therapy;2021-11-02

2. Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib;Journal of Thoracic Oncology;2019-04

3. Lung Injury Caused by Pharmacologic Agents;Kendig's Disorders of the Respiratory Tract in Children;2019

4. Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents;YAKUGAKU ZASSHI;2018-12-01

5. Surfactant protein D is a useful biomarker for monitoring acute lung injury in rats;Experimental Lung Research;2016-07-02